Literature DB >> 34312555

A 'mix and match' approach to SARS-CoV-2 vaccination.

Meagan E Deming1, Kirsten E Lyke2.   

Abstract

Entities:  

Year:  2021        PMID： 34312555     DOI： 10.1038/s41591-021-01463-x

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients.

Authors:  David Cucchiari; Natalia Egri; Marta Bodro; Sabina Herrera; Jimena Del Risco-Zevallos; Joaquim Casals-Urquiza; Frederic Cofan; Asunción Moreno; Jordi Rovira; Elisenda Banon-Maneus; Maria J Ramirez-Bajo; Pedro Ventura-Aguiar; Anna Pérez-Olmos; Marta Garcia-Pascual; Mariona Pascal; Anna Vilella; Antoni Trilla; José Ríos; Eduard Palou; Manel Juan; Beatriu Bayés; Fritz Diekmann
Journal:  Am J Transplant       Date:  2021-08-04       Impact factor: 9.369

2.  Seroconversion rates following COVID-19 vaccination among patients with cancer.

Authors:  Astha Thakkar; Jesus D Gonzalez-Lugo; Niyati Goradia; Radhika Gali; Lauren C Shapiro; Kith Pradhan; Shafia Rahman; So Yeon Kim; Brian Ko; R Alejandro Sica; Noah Kornblum; Lizamarie Bachier-Rodriguez; Margaret McCort; Sanjay Goel; Roman Perez-Soler; Stuart Packer; Joseph Sparano; Benjamin Gartrell; Della Makower; Yitz D Goldstein; Lucia Wolgast; Amit Verma; Balazs Halmos
Journal:  Cancer Cell       Date:  2021-06-05       Impact factor: 31.743

3.  Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Authors:  Joana Barros-Martins; Swantje I Hammerschmidt; Anne Cossmann; Ivan Odak; Metodi V Stankov; Gema Morillas Ramos; Alexandra Dopfer-Jablonka; Annika Heidemann; Christiane Ritter; Michaela Friedrichsen; Christian Schultze-Florey; Inga Ravens; Stefanie Willenzon; Anja Bubke; Jasmin Ristenpart; Anika Janssen; George Ssebyatika; Günter Bernhardt; Jan Münch; Markus Hoffmann; Stefan Pöhlmann; Thomas Krey; Berislav Bošnjak; Reinhold Förster; Georg M N Behrens
Journal:  Nat Med       Date:  2021-07-14       Impact factor: 53.440
  3 in total
  22 in total

1.  Durability of SARS-CoV-2 Specific IgG Antibody Responses Following Two Doses of Match and Mixed COVID-19 Vaccines Regimens in Saudi Population.

Authors:  Ayman Mubarak; Saeedah Almutairi; Abulrahman D Al-Dhabbah; Shaha Y Aldabas; Rauf Bhat; Mahfoudh M Alqoufail; Mostafa A Abdel-Maksoud; Taghreed N Almanaa; Mohamed A Farrag; Wael Alturaiki
Journal:  Infect Drug Resist       Date:  2022-07-15       Impact factor: 4.177

2.  Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients.

Authors:  Tamara Davidovic; Judith Schimpf; Armin Abbassi-Nik; Richard Stockinger; Hannelore Sprenger-Mähr; Karl Lhotta; Emanuel Zitt
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 3.  The use of viral vectors in vaccine development.

Authors:  Tatianna Travieso; Jenny Li; Sneha Mahesh; Juliana Da Fonzeca Redenze E Mello; Maria Blasi
Journal:  NPJ Vaccines       Date:  2022-07-04       Impact factor: 9.399

4.  COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps.

Authors:  Jeffrey V Lazarus; Salim S Abdool Karim; Lena van Selm; Jason Doran; Carolina Batista; Yanis Ben Amor; Margaret Hellard; Booyuel Kim; Christopher J Kopka; Prashant Yadav
Journal:  BMJ Glob Health       Date:  2022-04

5.  Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study.

Authors:  Davide Firinu; Andrea Perra; Marcello Campagna; Roberto Littera; Federico Meloni; Francesca Sedda; Maria Conti; Giulia Costanzo; Monica Erbi; Gianmario Usai; Carlotta Locci; Mauro Giovanni Carta; Riccardo Cappai; Germano Orrù; Stefano Del Giacco; Ferdinando Coghe; Luchino Chessa
Journal:  Vaccines (Basel)       Date:  2021-12-14

Review 6.  COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts.

Authors:  Ronak Rashedi; Noosha Samieefar; Niloofar Masoumi; Sahar Mohseni; Nima Rezaei
Journal:  J Med Virol       Date:  2021-11-30       Impact factor: 20.693

7.  Researchers getting closer to a "universal" flu vaccine.

Authors:  Carolyn Beans
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-01       Impact factor: 12.779

8.  Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old.

Authors:  Giuliana X Medeiros; Greyce Luri Sasahara; Jhosiene Y Magawa; João Paulo S Nunes; Fernanda R Bruno; Andreia C Kuramoto; Rafael R Almeida; Marcelo A Ferreira; Guilherme P Scagion; Érika D Candido; Fabyano B Leal; Danielle B L Oliveira; Edison L Durigon; Roberto Carlos V Silva; Daniela S Rosa; Silvia B Boscardin; Verônica Coelho; Jorge Kalil; Keity S Santos; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

9.  Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants.

Authors:  Bhaswati Chatterjee; Suman S Thakur
Journal:  Expert Rev Vaccines       Date:  2022-01-11       Impact factor: 5.217

Review 10.  SARS-CoV-2 Variants, Vaccines, and Host Immunity.

Authors:  Priyal Mistry; Fatima Barmania; Juanita Mellet; Kimberly Peta; Adéle Strydom; Ignatius M Viljoen; William James; Siamon Gordon; Michael S Pepper
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.